HB 4012 expands Texas law governing health care and insurance fraud by creating a new, specific criminal offense for fraudulent conduct directed at health benefit plan issuers. The bill defines key terms such as “health benefit claim,” “health benefit plan,” and “health benefit plan issuer,” and makes it an offense to knowingly make false statements, conceal material information, submit improper claims, or conspire to obtain unauthorized payments or benefits from a health plan. It also revises criminal penalty levels based on the dollar amount involved and the number of fraudulent claims, with offenses ranging from misdemeanors to first-degree felonies.
The bill also creates a civil enforcement framework in the Insurance Code. It authorizes the state to recover payments, interest, and civil penalties from violators, and it allows private persons to file qui tam-style civil actions on behalf of themselves and the state. Those private actions are subject to sealing, attorney general review, possible state intervention, limits on dismissal and settlement, anti-retaliation protections, and award provisions for private claimants, the Department of Insurance, and injured health benefit plan issuers. The bill further directs the Texas Department of Insurance and the Health and Human Services Commission Office of Inspector General to coordinate through a fraud prevention partnership to detect and prevent health care fraud across public and private markets.
In practical terms, the bill would broaden enforcement tools against health care fraud and insurance fraud in Texas, especially fraud involving private health plans as well as Medicaid-related systems. It would amend the Penal Code, Insurance Code, Government Code, and Code of Criminal Procedure, and it would apply only to offenses committed on or after September 1, 2025. The bill also permits courts to consider total pecuniary loss to the affected health plan or program when determining restitution and punishment.
The general sentiment reflected in the available record is limited because there were no committee transcripts or recorded votes included, but the bill’s structure suggests a strong enforcement-oriented approach with support for stronger fraud detection and recovery mechanisms. The fact that the bill was postponed on May 10, 2025 indicates it did not advance immediately, though the record does not explain why. Overall, the bill appears designed to strengthen anti-fraud oversight rather than to reduce regulation.
The main points of contention likely center on the bill’s expansion of civil liability and private enforcement. The qui tam-style provisions, sealing requirements, state intervention rules, and award structure may raise concerns about litigation incentives, attorney general control, and the potential for burdens on insurers, providers, and defendants. At the same time, supporters would likely emphasize the bill’s anti-fraud benefits, coordination between agencies, and enhanced remedies for protecting public funds, health plan issuers, and vulnerable populations such as elderly persons, people with disabilities, and minors.
HB 4012 would create a new civil remedies chapter in the Insurance Code, add a fraud prevention partnership in the Insurance Code, amend the Government Code to expand coordination authority for the Office of Inspector General, and revise the Penal Code to create and define a new health care and insurance fraud offense. It would also update criminal punishment provisions and evidentiary rules in the Code of Criminal Procedure for offenses under Section 35A.02, Penal Code. The bill would affect health benefit plan issuers, Medicaid managed care organizations, private claimants, the Attorney General, the Department of Insurance, and HHSC/OIG enforcement operations.
No committee transcript or vote record was provided, so there is no direct evidence of debate or partisan division in the available materials. The bill’s text reflects a generally pro-enforcement, anti-fraud policy stance, with multiple mechanisms to detect, prosecute, and recover losses from fraudulent health care and insurance conduct. Its postponement suggests the measure did not move smoothly, but the record does not show whether that was due to policy disagreement, procedural timing, or other legislative priorities.
Likely areas of contention include the bill’s private right of action, which allows individuals to sue on behalf of the state and share in recoveries, and the extent to which that model could encourage opportunistic litigation. Another possible issue is the breadth of the new offense and civil liability provisions, which reach conduct involving health benefit plan issuers and claims that may be unauthorized, inappropriate, or unsupported by a treating provider. Insurers, providers, and defense interests may also question the award structure, sealed filings, and state control over dismissal and settlement, while supporters would likely argue these tools are necessary to uncover and deter sophisticated fraud.